Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of different doses and
administration regimens of Stimotimagene copolymerplasmid in patients with histologically
confirmed diagnosis of solid tumor and/or its metastases.